Prostamax
$59.90
- Buy 5 and save 10%
- Buy 10 and save 15%
Legal Notice Regarding This Product
THIS PRODUCT IS STRICTLY INTENDED FOR RESEARCH USE ONLY. It is designated solely as a research chemical. Usage is confined to in vitro testing and laboratory experimentation exclusively. Information available on our website about this product is for educational purposes only and should not be interpreted as an endorsement or directive for use outside these bounds. Introducing this product into humans or animals by any route is strictly prohibited by law. Handling of this product should be undertaken only by licensed, qualified professionals.
This product is not to be used as a drug, food, or cosmetic. Misbranding, misusing, or mislabeling this product as a drug, food, or cosmetic is illegal. Users are responsible for complying with all applicable laws and regulations regarding the handling and use of this product.
Batch:BP4527C
| Dates |
19 June 2024
Avg Mass:
20 mg
|
|---|---|
| Janoshik Lab Results |
19.46 mg
Full Report:
|
| MZ Biolabs Lab Results | 99.915% |
It was established that Prostamax reduces intensity of signs of a chronic inflammation (swelling, hyperemia of vessels, lymphoid infiltration), prevents development of sclerotic and atrophic processes such as chronic aseptic prostatitis. It is shown that the agent intensifies sexual activity of animals. Efficiency of the preparation Prostamax surpasses that among widespread prostatotropic agents derived from the extract of Serenoa repens and prostate of animals.
Borovskaya, T. , Pakhomova, A. , Vychuzhanina, A. , Poluektova, M. , Fomina, T. , Ermolaeva, L. , Schemerova, J. , Granstrem, O. and Neplochov, E. (2013) Experimental studying of the drug efficiency Prostamax in the therapy of chronic aseptic prostatitis and its complications. Modern Research in Inflammation, 2, 54-58. doi: 10.4236/mri.2013.23007.
Prostamax
$59.90
